Fortress Biotech (NASDAQ:FBIOP) Stock Price Down 1.9% – Time to Sell?

Fortress Biotech, Inc. (NASDAQ:FBIOP)’s share price was down 1.9% during mid-day trading on Monday . The stock traded as low as $6.80 and last traded at $6.87. Approximately 7,918 shares changed hands during mid-day trading, a decline of 46% from the average daily volume of 14,778 shares. The stock had previously closed at $7.00.

Fortress Biotech Stock Performance

The stock has a 50 day moving average price of $7.97 and a two-hundred day moving average price of $7.61.

Fortress Biotech (NASDAQ:FBIOP) last posted its quarterly earnings results on Thursday, May 12th. The company reported ($0.11) earnings per share for the quarter. The firm had revenue of $11.59 million during the quarter.

About Fortress Biotech

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.